Evidence map›Paper›PMID 29195082›Full record

ArticleInternational journal for parasitology2018

A cell culture platform for Cryptosporidium that enables long-term cultivation and new tools for the systematic investigation of its biology.

Christopher N Miller, Lyne Jossé, Ian Brown, Ben Blakeman, Jane Povey, Lyto Yiangou, Mark Price, Jindrich Cinatl, Wei-Feng Xue, Martin Michaelis and 1 more

Abstract read
In one paragraph

Article in International journal for parasitology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Food and waterborne parasitology · 2021
    Review
  12. Review
  13. The Mucosal Innate Immune Response toFrontiers in cellular and infection microbiology · 2021
    Review
  14. Review
  15. Analysis of Long Non-Coding RNA inFrontiers in cellular and infection microbiology · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christopher N MillerLaboratory of Molecular & Evolutionary Parasitology, RAPID Group, School of Biosciences, University of Kent, Canterbury, UK; School of Biosciences, University of Kent, Canterbury, UK.
Lyne JosséLaboratory of Molecular & Evolutionary Parasitology, RAPID Group, School of Biosciences, University of Kent, Canterbury, UK; School of Biosciences, University of Kent, Canterbury, UK; Industrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK.
Ian BrownSchool of Biosciences, University of Kent, Canterbury, UK.
Ben BlakemanSchool of Biosciences, University of Kent, Canterbury, UK.
Jane PoveyIndustrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK.
Lyto YiangouLaboratory of Molecular & Evolutionary Parasitology, RAPID Group, School of Biosciences, University of Kent, Canterbury, UK; School of Biosciences, University of Kent, Canterbury, UK; Industrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK.
Mark PriceSchool of Physical Sciences, University of Kent, Canterbury, UK.
Jindrich CinatlInstitut für Medizinische Virologie, Klinikum der Goethe-Universität, Frankfurt am Main, Germany.
Wei-Feng XueSchool of Biosciences, University of Kent, Canterbury, UK.
Martin MichaelisSchool of Biosciences, University of Kent, Canterbury, UK; Industrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK. Electronic address: M.Michaelis@kent.ac.uk.
Anastasios D TsaousisLaboratory of Molecular & Evolutionary Parasitology, RAPID Group, School of Biosciences, University of Kent, Canterbury, UK; School of Biosciences, University of Kent, Canterbury, UK. Electronic address: A.Tsaousis@kent.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/M009971/1
6 · The paper itself

Abstract

Cryptosporidium parasites are a major cause of diarrhoea that pose a particular threat to children in developing areas and immunocompromised individuals. Curative therapies and vaccines are lacking, mainly due to lack of a long-term culturing system of this parasite. Here, we show that COLO-680N cells infected with two different Cryptosporidium parvum strains produce sufficient infectious oocysts to infect subsequent cultures, showing a substantial fold increase in production, depending on the experiment, over the most optimistic HCT-8 models. Oocyst identity was confirmed using a variety of microscopic- and molecular-based methods. This culturing system will accelerate research on Cryptosporidium and the development of anti-Cryptosporidium drugs.

Indexed as

AnimalsCell Line, TumorCells, CulturedCryopreservationCryptosporidium parvumHumansLipidsMicroscopy, Atomic ForceMicroscopy, Electron, ScanningOocystsProteomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTime FactorsLipidsAtomic force microscopyCell cultureCOLO-680NCryptosporidiumElectron microscopyImmunofluorescence microscopyLipidomicsProteomics

Identifiers

PMID29195082
PMCPMC5854368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.